Would Lilly Keep Us In A Hostile Takeover?





















Idiots, no clue about our history!

Pfizer has only grown through acquisitions and partnerships. Warner-Lambert, Pharmacia, Wyeth etc…. the pipeline investments have rarely been productive.

The A$$ who engineered his compensation was Hank McKinnell while he was CFO and then who made out like a bandit CEO by increasing gross sales by the acquisitions while destroying profitability and stock value until the Board of Directors fired him! The rest of the leaders till now have just been riding this lumbering behemoth.

Our only recent growth is because of manufactured pandemic to get rid of you know who. Lucky we were lucky to be in-bed BioNTech, again not our development.

No body is by the lame dumpster fire!
 








I actually think Merck is a better fit to acquire PFE. Keep the best of the portfolio and pipeline, sell off the rest. Even better opportunity to cut costs as vaccines and oncology fit easily in their existing structure of sales, marketing, medical, legal, etc. same opportunity to pocket PFE retained cash from the covid windfall, and do something more productive than PFE has accomplished.

Merck is back near 10 year highs in stock price, PFE remains near 10 year lows. Merck learned the risks of leadership being overly focused on ESG boondoggles. They would clear the top leadership quickly. Unfortunately due to synergies of portfolios, they could cut throughout.
 




I actually think Merck is a better fit to acquire PFE. Keep the best of the portfolio and pipeline, sell off the rest. Even better opportunity to cut costs as vaccines and oncology fit easily in their existing structure of sales, marketing, medical, legal, etc. same opportunity to pocket PFE retained cash from the covid windfall, and do something more productive than PFE has accomplished.

Merck is back near 10 year highs in stock price, PFE remains near 10 year lows. Merck learned the risks of leadership being overly focused on ESG boondoggles. They would clear the top leadership quickly. Unfortunately due to synergies of portfolios, they could cut throughout.

Seagen shareholders are enjoying the COVID windfall. There isn’t much left. Taxpayer dollars shifted to very few on a massive scale.
 




Seagen shareholders are enjoying the COVID windfall. There isn’t much left. Taxpayer dollars shifted to very few on a massive scale.

In December PFE reported having about $44B in cash. Also took on about $31B in debt to buy Seagen.

Whoever buys PFE will get Seagen the debt and the cash. PFE has lost over half its value in the past year, down over $144B in August and down further since then. Buy the assets on sale, cut most of the duplicative cost. Unfortunately AB and his cronies probably have a big payout cooked into the deal. They’ll make generational wealth by destroying the company.

Fire Albert before he can be rewarded for destroying a once proud healthcare business.
 












Idiots, no clue about our history!

Pfizer has only grown through acquisitions and partnerships. Warner-Lambert, Pharmacia, Wyeth etc…. the pipeline investments have rarely been productive.

The A$$ who engineered his compensation was Hank McKinnell while he was CFO and then who made out like a bandit CEO by increasing gross sales by the acquisitions while destroying profitability and stock value until the Board of Directors fired him! The rest of the leaders till now have just been riding this lumbering behemoth.

Our only recent growth is because of manufactured pandemic to get rid of you know who. Lucky we were lucky to be in-bed BioNTech, again not our development.

No body is by the lame dumpster fire!


I think you meant: NOBODY IS GOING TO BUY THIS LAME DUMPSTER FIRE!

Agreed.
 




In December PFE reported having about $44B in cash. Also took on about $31B in debt to buy Seagen.

Whoever buys PFE will get Seagen the debt and the cash. PFE has lost over half its value in the past year, down over $144B in August and down further since then. Buy the assets on sale, cut most of the duplicative cost. Unfortunately AB and his cronies probably have a big payout cooked into the deal. They’ll make generational wealth by destroying the company.

Fire Albert before he can be rewarded for destroying a once proud healthcare business.
your forgetting the rub, they also get all the employees, many of whom they would not want to keep. Who would want to take that on? Merck was looking at Seagen for far less money and decided their pipeline wasn't worth it, you think our R&D and Business Development are smarter?
 




your forgetting the rub, they also get all the employees, many of whom they would not want to keep. Who would want to take that on? Merck was looking at Seagen for far less money and decided their pipeline wasn't worth it, you think our R&D and Business Development are smarter?
Merck or any other buyer gets PFE at more than 50% discount to prior year value. Seagen is now part and parcel to that acquisition. Plus they get $44B in retained cash
 




your forgetting the rub, they also get all the employees, many of whom they would not want to keep. Who would want to take that on? Merck was looking at Seagen for far less money and decided their pipeline wasn't worth it, you think our R&D and Business Development are smarter?
They don't have to include employees in the deal.
 








Agree, there is no rub. Cost cutting includes excess headcount from the acquired company. The acquirer gets to books the sales and the cost reductions from cutting employees, programs, facilities, duplicated services, etc.
That's exactly what we did to Parke Davis and Pharmacy Upjohn in the Old Days. Well, kinda. Qw didnt really have to cut, as many of them refused to work here.
 




JP Morgan Healthcare meeting in San Francisco this week. I believe they have our best interests as employees in mind. Don’t listen to the “sky is falling” posters. We are the companies most valued asset.